ヘパリン市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、投与経路別、最終用途別、地域別セグメント、競合、2020年～2030年

ヘパリンの世界市場規模は2024年に64億8,000万米ドルとなり、予測期間では2030年までCAGR 5.96%で堅調な成長が予測されています。

世界のヘパリン市場は、医薬品・ヘルスケア産業の重要なセグメントであり、血栓性疾患の予防と治療において極めて重要な役割を果たしています。天然由来の抗凝固剤であるヘパリンは、主に深部静脈血栓症（DVT）、肺塞栓症（PE）、その他の凝固障害などの予防・管理に使用されます。この市場は、心血管疾患の罹患率の上昇、高齢化人口の増加、世界の外科手術の増加などを背景に、近年大きな成長を遂げています。

市場概要
予測期間	2026-2030
市場規模：2024年	64億8,000万米ドル
市場規模：2030年	91億米ドル
CAGR：2025年～2030年	5.96%
急成長セグメント	低分子ヘパリン
最大市場	北米

市場促進要因

用途の拡大

市場の課題

規制強化とコンプライアンス

主な市場動向

アプリケーションの拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のヘパリン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（低分子量ヘパリン（LMWH）、超低分子量ヘパリン（ULMWH））
  • 用途別（静脈血栓塞栓症、冠動脈疾患、腎機能障害、心房細動、その他）
  • 投与経路別（静脈内、皮下）
  • 用途別（病院・診療所、外来診療センター、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • 用途別
  • 投与経路別
  • 最終用途別
  • 地域別

第5章 アジア太平洋地域のヘパリン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • 投与経路別
  • 最終用途別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州のヘパリン市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米のヘパリン市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米のヘパリン市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカのヘパリン市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界のヘパリン市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• GlaxoSmithKline plc（GSK）
• Pfizer Inc.
• Sanofi AG
• Dr. Reddy's Laboratories Ltd.
• Aspen Holdings
• B. Braun Medical Inc.
• Fresenius SE & Co. KGaA
• Novartis AG
• Sandoz（Novartis AG）

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Heparin Market was valued at USD 6.48 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.96% through 2030. The global heparin market is a vital segment of the pharmaceutical and healthcare industry, playing a pivotal role in the prevention and treatment of thrombotic disorders. Heparin, a naturally occurring anticoagulant, is primarily used to prevent and manage conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and other clotting disorders. This market has witnessed significant growth in recent years, driven by a rising incidence of cardiovascular diseases, a growing aging population, and increasing surgical procedures globally.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 6.48 Billion
Market Size 2030	USD 9.10 Billion
CAGR 2025-2030	5.96%
Fastest Growing Segment	Low Molecular Weight Heparin
Largest Market	North America

Key Market Drivers

Expanding Applications

Expanding applications of heparin have emerged as a significant driver behind the growth of the global heparin market. Traditionally known as an anticoagulant, heparin has ventured into new therapeutic domains, broadening its market potential and fostering increased demand. Researchers and healthcare professionals have recognized its diverse properties, leading to its use in several medical conditions beyond its original scope. For instance, an October 2023 NCBI article highlighted that in the U.S., someone requires a blood transfusion every two seconds, playing a crucial role in saving lives. With only 62 out of 171 countries relying entirely on voluntary unpaid blood donations, maintaining a sufficient and safe blood supply remains a challenge. As blood transfusion efforts expand, the demand for heparin is expected to rise, supporting successful procedures and enhancing patient outcomes.

One of the key areas where heparin's applications have expanded is in the treatment of cancer. Heparin's anti-inflammatory and anti-angiogenic properties make it a promising candidate for cancer therapy. It has been utilized in cancer research to inhibit the growth of blood vessels that supply tumors, a process known as angiogenesis. By impeding angiogenesis, heparin helps curb the tumor's blood supply, potentially limiting its growth and spread. As research in this area continues, heparin-based cancer therapies are gaining traction, contributing to the growth of the heparin market.

Heparin-coated medical devices have gained prominence in the healthcare industry. These devices, such as catheters and stents, are designed with a heparin-coated surface to reduce the risk of thrombosis and infection. Heparin's anticoagulant properties, when applied to medical equipment, help prevent blood clot formation and improve the safety of various medical procedures. As healthcare facilities increasingly adopt these advanced technologies, the demand for heparin-coated devices is on the rise, further fueling the expansion of heparin's applications and market growth.

Key Market Challenges

Regulatory Scrutiny and Compliance

The global heparin market, a crucial component of the pharmaceutical and healthcare industry, faces significant challenges stemming from rigorous regulatory scrutiny and compliance requirements imposed by health authorities worldwide. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others, have established stringent guidelines to safeguard the safety and quality of heparin products. These regulations are essential to protect patient health and prevent adverse events linked to contaminated or substandard heparin. However, compliance with these multifaceted guidelines is a significant challenge for manufacturers and suppliers.

The complexity of heparin production, which involves sourcing raw materials from porcine intestines or other animal sources and then processing them into pharmaceutical-grade products, necessitates adherence to Good Manufacturing Practices (GMP) at every stage. Ensuring the purity and safety of heparin requires extensive quality control measures, traceability systems, and rigorous documentation. In the pursuit of compliance, companies must invest substantially in infrastructure, skilled personnel, and advanced technologies. This investment raises production costs, which can ultimately impact the pricing and affordability of heparin-based therapies for patients.

Key Market Trends

Expanding Applications

Expanding applications of heparin have emerged as a significant driver behind the growth of the global heparin market. Traditionally known as an anticoagulant, heparin has ventured into new therapeutic domains, broadening its market potential and fostering increased demand. Researchers and healthcare professionals have recognized its diverse properties, leading to its use in several medical conditions beyond its original scope.

One of the key areas where heparin's applications have expanded is in the treatment of cancer. Heparin's anti-inflammatory and anti-angiogenic properties make it a promising candidate for cancer therapy. It has been utilized in cancer research to inhibit the growth of blood vessels that supply tumors, a process known as angiogenesis. By impeding angiogenesis, heparin helps curb the tumor's blood supply, potentially limiting its growth and spread. As research in this area continues, heparin-based cancer therapies are gaining traction, contributing to the growth of the heparin market.

Key Market Players

• GlaxoSmithKline plc (GSK)
• Pfizer Inc.
• Sanofi AG
• Dr. Reddy's Laboratories Ltd.
• Aspen Holdings
• B. Braun Medical Inc.
• Fresenius SE & Co. KGaA
• Novartis AG
• Sandoz (Novartis AG)

Report Scope:

In this report, the Global Heparin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Heparin Market, By Application:

• Venous Thromboembolism
• Coronary Artery Disease
• Renal Impairment
• Atrial Fibrillation
• Others

Heparin Market, By Route of Administration:

• Intravenous
• Subcutaneous

Heparin Market, By End Use:

• Hospitals & Clinics
• Ambulatory care Centers
• Others

Heparin Market, By Type:

• Low Molecular Weight Heparin (LMWH)
• Ultra-Low Molecular Weight Heparin (ULMWH)

Heparin Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Heparin Market.

Available Customizations:

Global Heparin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Heparin Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH))
  • 4.2.2. By Application (Venous Thromboembolism, Coronary Artery Disease, Renal Impairment, Atrial Fibrillation, Others)
  • 4.2.3. By Route of Administration (Intravenous, Subcutaneous)
  • 4.2.4. By End Use (Hospitals & Clinics, Ambulatory care Centers, Others)
  • 4.2.5. By Region
  • 4.2.6. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Application
  • 4.3.3. By Route of Administration
  • 4.3.4. By End Use
  • 4.3.5. By Region

5. Asia Pacific Heparin Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Application
  • 5.2.3. By Route of Administration
  • 5.2.4. By End Use
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Heparin Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Application
      • 5.3.1.2.3. By Route of Administration
      • 5.3.1.2.4. By End Use
  • 5.3.2. India Heparin Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Application
      • 5.3.2.2.3. By Route of Administration
      • 5.3.2.2.4. By End Use
  • 5.3.3. Australia Heparin Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Application
      • 5.3.3.2.3. By Route of Administration
      • 5.3.3.2.4. By End Use
  • 5.3.4. Japan Heparin Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Application
      • 5.3.4.2.3. By Route of Administration
      • 5.3.4.2.4. By End Use
  • 5.3.5. South Korea Heparin Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Application
      • 5.3.5.2.3. By Route of Administration
      • 5.3.5.2.4. By End Use

6. Europe Heparin Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Route of Administration
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Heparin Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Route of Administration
      • 6.3.1.2.4. By End Use
  • 6.3.2. Germany Heparin Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Route of Administration
      • 6.3.2.2.4. By End Use
  • 6.3.3. Spain Heparin Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Route of Administration
      • 6.3.3.2.4. By End Use
  • 6.3.4. Italy Heparin Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By Route of Administration
      • 6.3.4.2.4. By End Use
  • 6.3.5. United Kingdom Heparin Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By Route of Administration
      • 6.3.5.2.4. By End Use

7. North America Heparin Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Route of Administration
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Heparin Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Route of Administration
      • 7.3.1.2.4. By End Use
  • 7.3.2. Mexico Heparin Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Route of Administration
      • 7.3.2.2.4. By End Use
  • 7.3.3. Canada Heparin Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Route of Administration
      • 7.3.3.2.4. By End Use

8. South America Heparin Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Route of Administration
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Heparin Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Route of Administration
      • 8.3.1.2.4. By End Use
  • 8.3.2. Argentina Heparin Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Route of Administration
      • 8.3.2.2.4. By End Use
  • 8.3.3. Colombia Heparin Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Route of Administration
      • 8.3.3.2.4. By End Use

9. Middle East and Africa Heparin Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Route of Administration
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Heparin Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Route of Administration
      • 9.3.1.2.4. By End Use
  • 9.3.2. Saudi Arabia Heparin Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Route of Administration
      • 9.3.2.2.4. By End Use
  • 9.3.3. UAE Heparin Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Route of Administration
      • 9.3.3.2.4. By End Use
  • 9.3.4. Egypt Heparin Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By Application
      • 9.3.4.2.3. By Route of Administration
      • 9.3.4.2.4. By End Use

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Heparin Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. GlaxoSmithKline plc (GSK)
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Pfizer Inc.
• 14.3. Sanofi AG
• 14.4. Dr. Reddy's Laboratories Ltd.
• 14.5. Aspen Holdings
• 14.6. B. Braun Medical Inc.
• 14.7. Fresenius SE & Co. KGaA
• 14.8. Novartis AG
• 14.9. Sandoz (Novartis AG)

15. Strategic Recommendations

16. About Us & Disclaimer